Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 16, 2022 09:44 ET | Source: Genetron Holdings Limited

Genetron Health to Participate in the Goldman Sachs Healthcare Corporate Day

BEIJING, June 16, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
June 15, 2022 06:00 ET | Source: Genetron Holdings Limited

Genetron Health Receives CAP Accreditation for its Maryland Laboratory

BEIJING, June 15, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
June 02, 2022 07:20 ET | Source: Genetron Holdings Limited

Genetron Health Reports Unaudited First Quarter 2022 Financial Results

BEIJING, June 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
June 02, 2022 06:00 ET | Source: Genetron Holdings Limited

Genetron Health Releases 10 New Research Results at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

BEIJING, June 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
June 01, 2022 06:00 ET | Source: Genetron Holdings Limited

Genetron Health Receives CE Mark for FusionScan Plus Kit for Human Multi-Genes

BEIJING, June 01, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
May 23, 2022 16:05 ET | Source: Genetron Holdings Limited

Genetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Investor Call on June 2, 2022

BEIJING, May 23, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
April 19, 2022 06:00 ET | Source: Genetron Holdings Limited

Genetron Health Receives CE Mark for Human B Lymphocyte Minimal Residual Disease Detection Kit Seq-MRD®

BEIJING, April 19, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
April 08, 2022 06:00 ET | Source: Genetron Holdings Limited

Genetron Health Presents 17 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2022

BEIJING, April 08, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
April 07, 2022 06:00 ET | Source: Genetron Holdings Limited

Publication in Clinical and Translational Medicine Demonstrates Mutation Capsule™’s potential in MRD Assay Developments

BEIJING, April 07, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
March 29, 2022 07:26 ET | Source: Genetron Holdings Limited

Genetron Health Announces Unaudited Fourth Quarter and Full Year 2021 Financial Results

BEIJING, March 29, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...